191 related articles for article (PubMed ID: 35282834)
1. Migraine susceptibility is modulated by food triggers and analgesic overuse via sulfotransferase inhibition.
Vuralli D; Arslan B; Topa E; de Morais AL; Gulbahar O; Ayata C; Bolay H
J Headache Pain; 2022 Mar; 23(1):36. PubMed ID: 35282834
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature.
Pacifici GM
Int J Clin Pharmacol Ther; 2004 Sep; 42(9):488-95. PubMed ID: 15487807
[TBL] [Abstract][Full Text] [Related]
3. The NSAID allosteric site of human cytosolic sulfotransferases.
Wang T; Cook I; Leyh TS
J Biol Chem; 2017 Dec; 292(49):20305-20312. PubMed ID: 29038294
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human sulfotransferases catalyzing the formation of p-cresol sulfate and identification of mefenamic acid as a potent metabolism inhibitor and potential therapeutic agent for detoxification.
Rong Y; Kiang TKL
Toxicol Appl Pharmacol; 2021 Aug; 425():115553. PubMed ID: 33915121
[TBL] [Abstract][Full Text] [Related]
5. Human adult and foetal liver sulphotransferases: inhibition by mefenamic acid and salicylic acid.
Vietri M; Pietrabissa A; Mosca F; Rane A; Pacific GM
Xenobiotica; 2001 Mar; 31(3):153-61. PubMed ID: 11465392
[TBL] [Abstract][Full Text] [Related]
6. Isoform-specific therapeutic control of sulfonation in humans.
Cook I; Wang T; Leyh TS
Biochem Pharmacol; 2019 Jan; 159():25-31. PubMed ID: 30423313
[TBL] [Abstract][Full Text] [Related]
7. Leaky gut and inflammatory biomarkers in a medication overuse headache model in male rats.
Vuralli D; Dağidir HG; Topa EA; Belen HB
Turk J Med Sci; 2024; 54(1):33-41. PubMed ID: 38812640
[TBL] [Abstract][Full Text] [Related]
8. Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo.
Al-Waili NS
Eur J Med Res; 2000 Apr; 5(4):176-82. PubMed ID: 10799353
[TBL] [Abstract][Full Text] [Related]
9. Double blind comparison of mefenamic acid and acetaminophen (paracetamol) in migraine.
Peatfield RC; Petty RG; Rose FC
Cephalalgia; 1983 Jun; 3(2):129-34. PubMed ID: 6347393
[TBL] [Abstract][Full Text] [Related]
10. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models.
Joo Y; Kim HS; Woo RS; Park CH; Shin KY; Lee JP; Chang KA; Kim S; Suh YH
Mol Pharmacol; 2006 Jan; 69(1):76-84. PubMed ID: 16223958
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Biological Evaluation and Pharmacokinetic Studies of Mefenamic Acid - N-Hydroxymethylsuccinimide Ester Prodrug as Safer NSAID.
Husain A; Ahuja P; Ahmad A; Khan SA
Med Chem; 2016; 12(6):585-91. PubMed ID: 26740206
[TBL] [Abstract][Full Text] [Related]
12. Chronic migraine with medication overuse: association between disability and quality of life measures, and impact of disease on patients' lives.
Raggi A; Schiavolin S; Leonardi M; Giovannetti AM; Bussone G; Curone M; Di Fiore P; Grazzi L; Usai S; D'Amico D
J Neurol Sci; 2015 Jan; 348(1-2):60-6. PubMed ID: 25434715
[TBL] [Abstract][Full Text] [Related]
13. The allosteric binding sites of sulfotransferase 1A1.
Cook I; Wang T; Falany CN; Leyh TS
Drug Metab Dispos; 2015 Mar; 43(3):418-23. PubMed ID: 25534770
[TBL] [Abstract][Full Text] [Related]
14. Dissociation between CSD-Evoked Metabolic Perturbations and Meningeal Afferent Activation and Sensitization: Implications for Mechanisms of Migraine Headache Onset.
Zhao J; Levy D
J Neurosci; 2018 May; 38(22):5053-5066. PubMed ID: 29703787
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
Schwedt TJ; Alam A; Reed ML; Fanning KM; Munjal S; Buse DC; Dodick DW; Lipton RB
J Headache Pain; 2018 May; 19(1):38. PubMed ID: 29797100
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents.
King RS; Ghosh AA; Wu J
Curr Drug Metab; 2006 Oct; 7(7):745-53. PubMed ID: 17073578
[TBL] [Abstract][Full Text] [Related]
17. Severe enteropathy with villous atrophy in prolonged mefenamic acid users - a currently under-recognized in previously well-recognized complication: Case report and review of literature.
Kaosombatwattana U; Limsrivilai J; Pongpaibul A; Maneerattanaporn M; Charatcharoenwitthaya P
Medicine (Baltimore); 2017 Nov; 96(44):e8445. PubMed ID: 29095288
[TBL] [Abstract][Full Text] [Related]
18. Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache.
Lucchesi C; Baldacci F; Cafalli M; Chico L; Lo Gerfo A; Bonuccelli U; Siciliano G; Gori S
Headache; 2015; 55(7):984-91. PubMed ID: 26129705
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory activity of mefenamic acid in mice models of cell-mediated and humoral immunity.
Shabbir A; Arshad HM; Shahzad M; Shamsi S; Ashraf MI
Indian J Pharmacol; 2016; 48(2):172-8. PubMed ID: 27127320
[TBL] [Abstract][Full Text] [Related]
20. Mefenamic Acid Attenuates Chronic Alcohol Induced Cognitive Impairment in Zebrafish: Possible Role of Cholinergic Pathway.
Rajesh V; Mridhulmohan M; Jayaseelan S; Sivakumar P; Ganesan V
Neurochem Res; 2018 Jul; 43(7):1392-1404. PubMed ID: 29796737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
